Navigation Links
Randomize Gene Sequences with New PCR Mutagenesis Kit

ure 5 shows a plot of mutation frequency (number of mutations per kb) as a function of target duplication number. As expected, mutation frequency increased with decreasing template concentration (increasing d value). For the lacZ gene, low mutation frequencies (0.08%-0.3%) were produced in PCRs employing 10 ng to 100 ng DNA template (d=5.6-9.4). PCRs performed with 10 pg, 100 pg, or 1 ng of DNA template (d=12.3-19.6) exhibited mutation frequencies ranging from 0.3% to 0.8%, while the highest mutation rates were achieved in reactions employing two (0.7%-1.4%; d=30-34) or three (1.6%; d=49) sequential PCRs.

Fig.5

The GeneMorph kit has been used to mutagenize other target genes, including a 2.5-kb polymerase gene and a 720-bp sequence encoding Green Fluorescent Protein (GFP). (Figure 5)

Mutational Spectrum of Mutazyme

Table 2 shows the types of mutations introduced by Mutazyme DNA polymerase. These data were compiled from DNA sequence analysis (37.5-kb total) of 45 clones randomly selected from lacZ mutagenesis studies. Mutations were distributed uniformly throughout the lacZ gene, rather than localized in hotspots (data not shown). Mutazyme DNA polymerase introduced all possible transition (purinepurine; pyrimidinepyrimidine) and transversion (purinepyrimidine; pyrimidinepurine) mutations, while insertions and deletions were relatively rare (~1%).

Mutational bias is most commonly analyzed by calculating either the ratio of transition (Ts) to transversion (Tv) mutations or the ratio of AT to GC changes (ATGC/GCAT). Since there are eight possible t
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
2. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
3. Big Blue Rodent Cell Cultures for Mutagenesis Studies
4. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Randomize Gene Sequences with New PCR Mutagenesis Kit

(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Drug Discovery Technologies - A G... ,, http://www.reportlinker.com/p0164246/Drug-...-Trends--Opportunities.html ,, Drug discovery ...y pharmaceutical company,s business strategy. Ther...
(Date:12/2/2009)...2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.... ONCY ) announced today that in connection with it...ters have exercised in full their over-allotment o...ach unit is comprised of one common share and 0.4 ...t a price of US$3.00 per unit. Each whole common s...
(Date:12/2/2009)... Israel, December 2 Gamida Cell an...reclinical (animal study) safety and,efficacy of a...om Weill,Cornell Medical College and Gamida Cell. ...anemias such as Cooley,s Anemia. , Gamida...pand, ex vivo,populations of stem/progenitor cell...
(Date:12/2/2009)...PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NAS...iopharmaceutical company focused on endocrine ther...od and Drug Administration (FDA) has granted Fast ...ay inhibitor compound, perifosine (KRX-0401), for ...oma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( KE...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... Christoph Sachse, , Andrew W... David Brown Ambion, Inc. , ... a powerful , tool for understa... wherein short double-stranded RNA...As (siRNAs) direct the degradation of transcripts ...
...s use and recommend , a number of differe...oincide , with the suggested controls det... Cell Biology [1]. Here we outline these vario...of each in RNAi experiments. , , ..., href="http://www.ambion....
...ior Scientist, , Ambion, Inc.) ...nterference (RNAi) , can be use..., studies occurred with the semin...ation describing the use of small interfering RNAs...in 2001. In less than two years, , ...
Other Biology Technology:siRNA Design: It's All in the Algorithm 2siRNA Design: It's All in the Algorithm 3siRNA Design: It's All in the Algorithm 4siRNA Design: It's All in the Algorithm 5siRNA Design: It's All in the Algorithm 6siRNA Design: It's All in the Algorithm 7siRNA Design: It's All in the Algorithm 8siRNA Design: It's All in the Algorithm 9siRNA Design: It's All in the Algorithm 10RNAi: The Controls You Need 2RNAi: The Controls You Need 3RNAi: The Controls You Need 4RNAi: The Controls You Need 5RNAi: The Controls You Need 6RNAi: The Controls You Need 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 2RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 3RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 4RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 6RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 8
(Date:12/4/2009)...l Botanic Gardens, Kew and the Natural History Mus...s far more widespread than previously thought, wit... least part way to being "meat eaters". A review p...nd modern insights into vegetable carnivory, is pu...Journal of the Linnean Society . , Carnivorous p...
(Date:12/4/2009)... model of heart cells, University of Iowa investig...me, calmodulin kinase II (CaM kinase), disrupts th...udy, which also involved Columbia University, was ...tational Biology . , "Recently, researchers hav... as a critical regulator of the heart,s response t...
(Date:12/3/2009)... Hausen and his co-workers discovered that specifi...al cancer. Scientists soon found out how these pat...y that the main culprits are viral proteins E6 and...ontrol functions, thus promoting cell growth. , ...Z have now discovered another mechanism by which t...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2Statement by Don Spence CEO Philips Home Healthcare Solutions Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 6050 1Statement by Don Spence CEO Philips Home Healthcare Solutions Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 6050 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 1Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 1Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 3
...ors roamed 60,000 years ago? ,Now you can find out...oject tracing the genetic and migratory history of...rom all over the world can supply their DNA to the...sity of Arizona in Tucson will do the genetic anal...undertaking to unravel the origins and migratory h...
...t the University of Pennsylvania School of Medicin...cer that closely mimics disease progression in hum...s for this deadly disease. Advanced pancreatic can...e-year survival rate after chemotherapy of only 17...nal Cancer Institute. , Sunil R. Hingorani, MD, Ph...
...geria Syndrome (HGPS) -- a disease associated with...ording to findings by scientists at the National C...utes of Health (NIH). Using specially modified seg... and Tom Misteli, PhD, reversed the abnormalities ...d with the key protein, lamin A. By demonstrating ...
Other Biology News:The biggest family tree ever 2The biggest family tree ever 3Disease progression model of pancreatic cancer developed by Penn researchers 2Disease progression model of pancreatic cancer developed by Penn researchers 3Cellular Defects in Premature Aging Disease are Reversible 2Cellular Defects in Premature Aging Disease are Reversible 3
...ovides excellent performance, reliability and flex..., including washing of ELISAs, cellular assays and...uch as for PCR clean-up. The platforms outstanding...ate washers, with options including a process cont...
...ts Laser Capture Microdissection (LCM) enables yo...uracy of molecular assays by starting with samples...ctures isolated from whole tissue or cytology samp...oped in 1996 at the National Institutes of Health ...
BioWorks 3.3 from Thermo Scientific
...screen, without Camera • The digimage sys...ion. It is computer free for compact space require... TFT color liquid crystal display is it's specific...rescent gels, colorimetric gels, auto radiography ...
Biology Products: